OnCo
institutionsInstitution

Cleveland Clinic Taussig Cancer Institute

Cleveland Clinic is a top US hospital with a Comprehensive Cancer Center (with Case Western) and a TNBC preventive vaccine programme.

Case Comprehensive Cancer Center partner; alpha-lactalbumin TNBC preventive vaccine (Tuohy) in phase 1; genitourinary and haematologic oncology strengths.

Location
Cleveland, US
Type
hospital
Newsweek 2026 oncology rank
#20
NCI designation
comprehensive
OnCo score
#22 · 69 points (40 Newsweek + 15 NCI + 14 from 7 linked objects) · ranking

Programmes

3top
  • TNBC preventive vaccine
  • GU oncology
  • Haematology

People

7top
Jame Abraham
Chair, Department of Hematology and Medical Oncology
Breast cancerClinical trialsCancer care delivery

Jame Abraham leads medical oncology at Cleveland Clinic and its breast cancer trial programme.

Jaroslaw P. Maciejewski
Chair, Department of Translational Hematology and Oncology Research
Myelodysplastic syndromesBone marrow failureClonal haematopoiesis

Jaroslaw Maciejewski is a leukaemia geneticist who defined the mutational landscape of myelodysplastic syndromes.

Justin D. Lathia
Melvin H. Burkhardt Endowed Chair for Neuro-Oncology Clinical Research; Vice Chair, Cardiovascular and Metabolic Sciences
Glioblastoma stem cellsSex differences in cancerTumour microenvironment

Justin Lathia studies glioblastoma stem cells and why brain tumours differ between men and women.

Nathan A. Pennell
Vice Chair of Clinical Research, Taussig Cancer Institute; Lung Cancer Medical Oncology Program
Lung cancerBiomarker testingClinical research operations

Lung cancer oncologist who has pushed for universal biomarker testing and better trial design.

Shilpa Gupta
Director, Genitourinary Medical Oncology
Bladder cancerKidney cancerImmunotherapy trials

Genitourinary oncologist leading bladder and kidney cancer trials and national guideline work.

Timothy A. Chan
Director, Global Center for Immunotherapy; Chair, Center for Immunotherapy and Precision Immuno-Oncology
ImmunogenomicsTumour mutational burdenHLA and immunotherapy response

Timothy Chan showed that tumour mutational burden predicts who benefits from checkpoint inhibitors.

Vincent K. Tuohy
Mort and Iris November Distinguished Chair in Innovative Breast Cancer Research, Lerner Research Institute
Preventive cancer vaccinesAlpha-lactalbuminTriple-negative breast cancer

Vincent Tuohy invented a preventive vaccine against triple-negative breast cancer, now in early human trials.

Connected

14top